Oral News and Research

RSS

WHO recommends switching to injectable polio vaccine

"[T]his month the World Health Organization (WHO) in Geneva, Switzerland, proposed a shift in [polio] vaccination strategy from oral vaccines to injected ones that may have to be administered in clinics," Nature reports, adding, "The change is needed to mop up the last remaining pockets of polio, but experts say that it poses challenges in [rural areas], which have poor access to health care."

16 Jan 2013

FDA approves Santarus’ UCERIS for induction of remission in patients with ulcerative colitis

Santarus, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved UCERIS (budesonide) extended release tablets for the induction of remission in patients with active, mild to moderate ulcerative colitis.

16 Jan 2013

CHOP to study antibiotic delivery to children after hospitalization for serious bacterial infection

The Children's Hospital of Philadelphia (CHOP) was awarded nearly $2M in research funding from the Patient-Centered Outcomes Research Institute (PCORI) to study antibiotic delivery to children returning home after hospitalization for a severe bacterial infection.

16 Jan 2013

Pfizer’s Quillivant XR now available in the U.S. for treatment of ADHD

Pfizer Inc. today announced that Quillivant XR (methylphenidate hydrochloride) CII for extended-release oral suspension is now available in the U.S. for the treatment of attention deficit hyperactivity disorder (ADHD).

16 Jan 2013

Diospyrin inactivates a drug target for tuberculosis in new way

A compound from the South African toothbrush tree inactivates a drug target for tuberculosis in a previously unseen way.

16 Jan 2013

Vitamin D claims for knee osteoarthritis questioned

The benefit of taking vitamin D supplements for the treatment of knee osteoarthritis has been challenged in a study published in JAMA.

14 Jan 2013

Morphine not first choice after neonatal surgery

Neonates and infants undergoing major surgery should be treated with postoperative intermittent intravenous acetaminophen as opposed to continuous morphine, research suggests.

14 Jan 2013

Dental diversion plan eases burden in busy EDs

Hospital emergency departments may benefit from having a diversion plan in place to deal with dental patients, say US researchers writing in the Journal of Oral and Maxillofacial Surgery.

14 Jan 2013

Human papillomavirus an etiologic factor in 6% of OCSCC cases

High-risk human papillomavirus is an etiologic factor in approximately 6% of cases of oral cavity squamous cell carcinoma, according to epidemiologic research.

14 Jan 2013

Communication key in helping patients adhere to medicine

Patients are less likely to take their medications properly if they feel their family doctor or other primary care clinician is failing to communicate with them adequately, suggests a US study published in the Archives of Internal Medicine.

14 Jan 2013

UCSF teams to study new ways to reduce childhood mortality and disease in developing nations

Two UCSF teams have received a total of $16 million from the Bill & Melinda Gates Foundation to study new ways to significantly reduce childhood mortality and disease in developing nations.

11 Jan 2013

Roundup: Advocates watching Calif. budget for Medi-Cal cuts; Mich. AG to appeal same-sex health benefits ruling; Kansas city seeks to extend health care tax

Brown's proposed budget will outline his plans for expanding health coverage under the new federal health care law, which is set to require increased coverage beginning in January 2014. The law will put hundreds of thousands of new enrollees into California's public insurance program, but the governor has raised concerns about what that will cost.

11 Jan 2013

Cholera could be contained in Haiti by vaccinating less than half the population

Cholera could be contained in Haiti by vaccinating less than half the population, University of Florida researchers suggest in a paper to be published Thursday in the journal Scientific Reports.

11 Jan 2013

New information on insulin and cell bonding mechanics

The discovery of insulin nearly a century ago changed diabetes from a death sentence to a chronic disease. Today a team that includes researchers from Case Western Reserve University School of Medicine announced a discovery that could lead to dramatic improvements in the lives of people managing diabetes.

11 Jan 2013

Tips for parents to safely help relieve child's flu symptoms

Doctors' offices are teeming with patients suffering from one of the worst outbreaks of cold and flu season in recent years. The Centers for Disease Control and Prevention has said that flu is at an elevated level across the nation. Though virus symptoms vary by age, children are especially vulnerable since they are unable to take over-the-counter medications to help alleviate symptoms.

10 Jan 2013

LM11A-31 effective at improving limb movement after spinal cord injury in mice

An experimental oral drug given to mice after a spinal cord injury was effective at improving limb movement after the injury, a new study shows.

10 Jan 2013

Concern regarding cefixime failure rate in gonorrhea patients

Results from a Canadian study add to those of prior studies suggesting that resistance of Neisseria gonorrhoeae to the cephalosporin antibiotic cefixime is increasing worldwide.

9 Jan 2013

High court turns away challenge to Obama administration stem cell policy

Meanwhile, the Supreme Court heard arguments in a case involving Medicaid and malpractice awards. In addition, the justices rejected an appeal from Social Security recipients who don't want Medicare benefits.

9 Jan 2013

Overall cancer death rates continue to decline in the U.S.: Report

The Annual Report to the Nation on the Status of Cancer, 1975-2009, shows that overall cancer death rates continued to decline in the United States among both men and women, among all major racial and ethnic groups, and for all of the most common cancer sites, including lung, colon and rectum, female breast, and prostate.

9 Jan 2013

CTI initiates enrollment in pacritinib Phase 3 trial for myelofibrosis

Cell Therapeutics, Inc. (CTI) today announced that the Company has initiated clinical trial sites and began enrolling patients in a Phase 3 clinical trial, known as PERSIST-1 or PAC325, for pacritinib, CTI's investigational JAK2 inhibitor, which is being evaluated for the treatment of patients with myelofibrosis.

9 Jan 2013